an-788 an-788 an-788, also known as nsd-788, is an experimental medication which was originated by neurosearch and is under development by aniona and saniona for the treatment of major depressive disorder. it was also under development for anxiety disorders, but development for this indication was discontinued. the drug acts as a serotonin–dopamine reuptake inhibitor (sdri). as of november of 2018, it is in an agreement for phase ii clinical trials for major depressive disorder. an-788clinical dataother namesnsd-788drug classmonoamine reuptake inhibitor; serotonin–dopamine reuptake inhibitoridentifierscas number1618658-43-7